The principal objective of the Hagerman laboratory is a greater understanding of the molecular basis of clinical involvement in fragile X syndrome and autism, with the goal of developing effective therapies for those neurodevelopmental disorders. Our efforts combine clinical and basic molecular research, the latter involving studies of nucleic acid structure, and gene expression at the level of transcription and translation.
Fragile X Syndrome
FXTAS
Autism

Hagerman Lab Publications
Click here to request a PDF file of a particular manuscript via email.

2007
2006
2005
2000-2004

Job Opportunities